Cannabidiol for Treatment of Recent-onset Psychosis With Comorbid Cannabis Use
Status:
Recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
This trial examines the efficacy of cannabidiol (CBD) versus risperidone for treatment of
psychosis and cessation of cannabis use in patients with recent-onset psychosis and comorbid
cannabis use.
Phase:
Phase 2
Details
Lead Sponsor:
Lone Baandrup
Collaborators:
Copenhagen University Hospital, Denmark Danish Center for Sleep Medicine Glostrup University Hospital, Copenhagen University of Copenhagen